XVIVO Perfusion AB (publ) has decided to change the date of reporting of the Report on Operations 2019 to January 30, 2020.
June 25, 2019
Gothenburg
Magnus Nilsson, CEO
XVIVO Perfusion AB (publ)
XVIVO Perfusion AB (publ) has decided to change the date of reporting of the Report on Operations 2019 to January 30, 2020.
June 25, 2019
Gothenburg
Magnus Nilsson, CEO
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31 788 2150, magnus.nilsson@xvivoperfusion.com
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
This information is information that Xvivo Perfusion AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 am CET on June 25, 2019.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.